KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) EPS (Basic): 2017-2024

Historic EPS (Basic) for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to -$2.96.

  • BioNTech SE's EPS (Basic) fell 31.08% to $0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.15, marking a year-over-year decrease of 185.46%. This contributed to the annual value of -$2.96 for FY2024, which is 171.09% down from last year.
  • According to the latest figures from FY2024, BioNTech SE's EPS (Basic) is -$2.96, which was down 171.09% from $4.16 recorded in FY2023.
  • In the past 5 years, BioNTech SE's EPS (Basic) registered a high of $48.25 during FY2021, and its lowest value of -$2.96 during FY2024.
  • Moreover, its 3-year median value for EPS (Basic) was $4.16 (2023), whereas its average is $13.59.
  • Its EPS (Basic) has fluctuated over the past 5 years, first spiked by 67,351.02% in 2021, then plummeted by 171.09% in 2024.
  • Over the past 5 years, BioNTech SE's EPS (Basic) (Yearly) stood at $0.07 in 2020, then soared by 67,351.02% to $48.25 in 2021, then declined by 18.00% to $39.57 in 2022, then slumped by 89.48% to $4.16 in 2023, then plummeted by 171.09% to -$2.96 in 2024.